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Study o f t he i n v i t r o pene t ra t ion o f t he top ica l 
g l ucoco r t i co i d betamethasone-17-va lera te 
f r o m so lu t i on - t ype gels i n to a mul t i layer membrane sys tem 
B A R B A R A B E N D A S 1 , A. GÖPFERICH 2 , G. LEE 2 and R. NEUBERT 1 
The in vitro transport of betamethasone-17-valerate (1) 
into a multilayer membrane system has been inves-
tigated. Subsaturated formulations of 1 were studied 
as formed by mixing appropriate propylene glycol/wa-
ter cosolvent systems. The A U C (drug concentration 
in acce ptor membrane as a function of time) and the 
diffusivity of the drug in the vehicle were used to 
evaluate the results of the in vitro transport. The 
importance and relationship between solubility, parti-
tion coefficient, and diffusivity for the process of in vitro 
penetration of 1 are discussed. 
Untersuchungen zur in vitro-Penetration von Bethame-
thason-17-valerat aus Lösungsgelen in ein Mehrschicht-
membransystem 
Gegenstand der Untersuchungen ist der in vitro-Trans-
port von Betamethason-17-valerat (l)aus Lösungsgelen 
in ein Mehrschichtmembranmodell . Als Hydrogele ka-
men Systeme mit unterschiedlichen Propylenglycol / 
Wasser-Mischungen zur Anwendung. Z u r Auswertung 
der Ergebnisse wurden die A U C (Arzneistoffkonzentra-
tion in der Akzeptormembran als Funk t ion der Zeit) 
und der Diffusionskoeffizienz des Arzneistoffes im Vehi -
kel herangezogen. Die Bedeutung und der Zusammen-
hang zwischen Lösl ichkei t , Verteilungskoeffizient und 
Diffusionskoeffizient für die in vitro-Penetration von 1 
werden diskutiert. 
1. Introduction 
The importance of the interactions between drug, vehicle, and 
skin for percutaneous absorption are complex, as can be 
appreciated from a study of the available literature [1-6]. 
There are various parameters that affect the mechanisms 
responsible for specific drug release and penetration. One way 
to improve the dermal absorption of drugs is to manipulate 
their physico-chemical properties by producing derivatives 
with increased potential for permeation through the skin 
barrier. M a n y investigations have been carried out to produce 
prodrugs with the aim to increase l ipophil ici ty. This changes 
related parameters like parti t ion coefficient, solubility and 
even diffusivity [7-16]. 
The dermal uptake properties of a drug are also influenced 
by the choice of the type of vehicle and its ingredients. Thus 
the interactions of the physico-chemical properties of a drug 
and vehicle play an important role for the delivery of the drug 
into the skin from its formulation [17-20]. Furthermore, the 
components of the vehicle are themselves able to penetrate 
into the skin. This can result in a decreased diffusional 
resistance of the stratum corneum [21-23]. 
In this study, betamethasone-17-valerate (1) in the mixed 
cosolvent system propylene glycol (PG)/water has been used 
to study solution-type gels as topical vehicles. The influence 
of P G on the in vitro penetration of the drug out of the vehicle 
into a membrane system has been investigated. The ratio of 
the 1 concentration in solution (C v ) to its saturated solubility 
in the gel (C s ) was maintained constant, with the drug only 
being present in the dissolved state. 
2. Investigations, results and discussion 
The in vitro penetration experiments were run using solution-
type formulations of 1 in simple hydrogels with varying 
content of cosolvent. T o classify the l ipophil ici ty of 1 its 
saturated solubility in the acceptor l ip id dodecanol (DD) , in 
propylene glycol (PG) and in water was determined (Table 1). 
It is slightly soluble in water, but shows a high solubility in 
D D . The percentage of dissolved 1 in water increases with 
increasing P G content (Fig. 1). If the ratio of C v to C s is kept 
constant for all systems investigated, then the same solubility 
conditions are established. F r o m previous results [31] one can 
expect that for fixed thermodynamic activity, the amount 
penetrated into the membrane wi l l be constant up to a certain 
value. Above this, the release of 1 wi l l be controlled by partit ion 
behaviour. 
Table 1 Solubility of 1 in D D , P G and water as solvent systems 
(mean value +SD, n = 4) 
D D P G Water 
Solubility 12.5 ± 1.0 3.0 ± 0.01 0.012 ± 0.008 
[mg/ml] 
In this study, the A U C was used as a parameter to estimate 
the amount and rate of in vitro penetration of 1 from each 
gel as a function of time and PG-content (Fig. 2). 
Consideration of the cumulative amount of 1 transported in 
dependence on the time shows that with P G content above 
50% the amount penetrated after 200 min decreases (Fig. 2). 
When the A U C is expressed as a function of P G content (see 
Table 2) it can be estimated that the in vitro penetration is 
independent of P G content up to 40%. The slight increase in 
A U C values in the range of 50 and 60% P G are caused by 
higher amounts of 1 being transported within the first 15 min 
(Fig. 3.). This increased penetration rate is caused by convec-
tive transport. It has been found that P G is able to penetrate 
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Fig . 1. Solubi l i ty of 1 in P G / w a t e r mixtures 
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F i g . 2. In vitro penetration of 1 from solution-type gels as function of P G 
considerably in the acceptor membranes [32]. D r u g molecules 
dissolved in the cosolvent are, therefore, transported with the 
cosolvent flow into the acceptor. W i t h increasing P G content 
in the gels, the amount of 1 penetrated into the acceptor 
decreases, although the extent of convection would be expect-
ed to increase. 
The study of the parti t ion behaviour of 1 between vehicle and 
acceptor indicates that the ability of 1 to distribute into the 
acceptor decreases with increasing P G content of the donor 
medium (Fig. 4). By comparing the solubili ty and partit ion 
behaviour as functions of P G content, it is evident that these 
two contrary processes result in an optimal cosolvent concen-
tration for the in vitro penetration of 1 [33-35]. The parti t ion 
coefficient wi l l be the most important parameter, provided 
the concentration of drug is in a constant relation to its 
saturated solubili ty and it other factors influencing the drug 
release, such as change in viscosity of the vehicle, can be 
neglected. The decrease in parti t ion coefficient seen with higher 
cosolvent concentration in the gels arises from a higher affinity 
of the drug for the vehicle, consequently lower uptake rates 
of 1 are measured. 
The diffusion coefficients for the 1 in the vehicles lie in the 
range of 1 0 " 7 cm 2 / s (Fig. 5) as is typically found for isotropic 
hydrogels. They are independent of the P G content up to 
40%, At higher P G contents, D decreases slightly but remains 
within the same order of magnitude. The higher affinity of 
the drug for the formulation at these large P G contents 
manifests itself in lower values for K . In accordance with 
Fick 's First law, these two changes result in a decrease in the 
amount of 1 penetrated. 
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F i g . 4. Penetrated amount of 1 in dependence of P G content in 15 min 
We conclude that both A U C and diffusivity can be used to 
evaluate the in vitro penetration of a l ipophil ic substance from 
simple hydrogels (Table 2). The calculation of diffusivity 
allows a quantitative estimation of the importance of the 
A U C . 
Table 2 Comparision of the parameters A U C and diffusivity for 
evaluating the in vitro penetration of 1 from hydrogels with varrying 
P G content 
P G content [%] A U C [% • minj D [cm 2 s] 
20 13690 1.105 E-007 
30 13639 1.179 E-007 
40 13439 1.173 E-007 
50 13866 8.204 E-008 
60 13734 8.006 E-008 
70 11743 6.4865 E-008 
80 11597 6.2296 E-008 
3. Experimental 
3.1. M a t e r i a l s 
Betamethasone-17-valerate (1) and propylene glycol ( P G ) were purchased from 
C O M Pha rma H a n d e l s - G m b H , H a m b u r g . C h l o r o f o r m , methanol and co l lo -
d ion (4% w/w) were provided by Laborchemie A p o l d a . Dodecano l ( D D ) , 
tetrazol ium blue and potassium hydroxide were purchased from M e r c k , 
Darmstadt and sod ium carboxymethylcel lulose from F l u k a Fe inchemikal ien 
G m b H , N e u - U l m . 
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Fig . 3. Penetrated amount of 1 in dependence of P G content wi th in 200 min Pig . 5. Par t i t ion coefficient of 1 between vehicle and acceptor l ip id 
3.2. M e t h o d s 
3.2.1. Solubility of \ in PG water mixtures 
A series of P G / w a t e r mixtures was prepared from 10 to 8 0 % P G in 10% (w/w) 
increments. D r u g was added to each unti l a suspension formed, which was then 
shaken for 24 h at 32 C + 1 C . The samples were centrifuged and the 
supernatant solutions were assayed for their drug content. The tetrazolium blue 
method for glucocort icoids was used. 
3.2.2. Determination of partition behaviour 
T o characterize the par t i t ion behaviour of 1 between the solution-type gels and 
the acceptor medium ( D D ) the penetration experiments were carried out for 
a finite time (300 min). The drug content in the membranes was then determined, 
and the par t i t ion coefficient (K) calculated according to Nernst : 
aaqu 
The fol lowing condi t ions have to be taken into account: 1. non ideal, dilute 
solutions were used; and 2. the formulat ion excipients, e.q. P G , could penetrate 
into the acceptor medium. 
3.2.3. Preparation of the gels 
A suitable amount of sodium carboxymethylcel lulose was mixed with the 
appropriate amount of P G and the mixture made up wi th disti l led water. The 
gels were then added to the drug and stirred to a homogenous formulat ion. 
3.2.4. In vitro membrane transport studies 
The mult i layer membrane system used has been described previously [24, 25]. 
A defined amount of the formulat ion (10 mg) was applied to the acceptor 
system, which was attached in a cell wi th a fixed appl ica t ion area (4 cm 2 ) . The 
acceptor system consists of one l ip id membrane to mainta in approximat ive 
sink condi t ions (acceptor loading after complete absorpt ion of the drug: 
1 10%). The experiments were carried out sixfold at 32 C ± 1 C in a 
temperature-controlled chamber. A t selected time intervals the model apparatus 
was removed from the chamber, the penetration cells were disassembled, the 
formulat ion remaining on the exposed surface was removed, and the membranes 
assayed for their content of 1. 
3.2.5. Extraction of the drug 
The separated membranes were extracted wi th 2 ml for each sample by shaking 
for 30 min . 
3.2.6. Analytical method 
The content of 1 in the various membranes of the model was assayed indirectly 
x = 0 x = 
F o r m u l a t i o n A c c e p t o r 
c ( x , t ) m ( t ) 
D 
d c ( 0 , t ) , . 
— = 0 c ( h , t ) = 0 
d x t 
f d c ( x , t ) 




Fig . 6. Sink model for describing the diffusional release of a drug from thin 
film into adjacent acceptor 
by measuring absorbance after reduction of tetrazolium blue through the 
oxida t ion of the ketol structure of the glucocor t icoid in alkaline solut ion. The 
absorbance of the formazan compound obtained was measured at 525 nm. 
3.2.7. Analysis of data 
The results were expressed as plots of 1 concentrat ion in the acceptor membrane 
versus time. The statistical moments of each curve were calculated according 
to Brockmeier [26, 27]. A c c o r d i n g to the literature, the A U C can be used for 
characterizing the extent of drug penetration into systems such as excised human 
skin and the membranes used here [28, 29]. 
Add i t i ona l ly , the diffusivity of the drug in each formulat ion was calculated. 
Theoret ical values for the time-dependent mass of drug in the acceptor 
membrane were fitted by the N e l d e r - M e a d method to the corresponding 
experimentally determined values. The calculat ion was based on a finite-
difference method [30] to approximate numerically the diffusion equation for 
the linear movement of a drug with constant diffusity, D . through a finite 
plane sheet: Dc(x, t) x x — c(x, t), = 0. where c(x. t) = concentrat ion in formula-
tion, x = space coordinate, and t = time. The sink model used is illustrated 
in F ig . 6 and describes the diffusional release of the drug from a thin film of 
formulat ion into an adjacent acceptor membrane. The latter is taken to act as 
a sink, resulting i n : c(h. t) = 0. The flux of drug entering the acceptor membrane. 
J, is equal to that leaving the formulat ion, i.e. J = dm (x. t) A d t | x h . 
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